trending Market Intelligence /marketintelligence/en/news-insights/trending/wkpyxu28utbqqnr7f8abfw2 content esgSubNav
In This List

Walgreens to pay $5.5M in drug overcharge probe

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

SEC Climate Disclosure Requirements Heating Up: How to Take Action

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms


Walgreens to pay $5.5M in drug overcharge probe

Walgreens Boots Alliance Inc.'s Walgreen Co. agreed to pay $5.5 million after allegedly overcharging workers for prescription drugs covered by the state workers' compensation insurance, according to a March 20 release from the Office of Attorney General Maura Healey.

Between 2008 and 2017, the Illinois-based drug retailer allegedly violated state consumer protection law by overcharging its workers for legitimate prescription drugs at various Walgreen pharmacies in Massachusetts. The drugs were covered by the employees' compensation insurance system, which takes care of certain medical expenses incurred by workers injured on the job.

"This settlement ensures that Walgreens does not profit from those transactions," Healey said.

As part of the settlement, the drug retailer will have to implement procedures to check overcharges on opioids and other drugs under the workers' compensation system in the future. In addition, future sales of the pharmacy chain will be subjected to an audit review by the attorney general's office.